Form D · Biotechnology
Biolog, Inc. /DE/
Hayward, CA · CIK 0001940250
Offering snapshot reported Feb 19, 2025 · SEC filing
- Reported sold
- $16.1M Offering amount: $17.1M
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Feb 10, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 19, 2025 | Initial | $16,122,991 | No comparison | 22 | SEC filing |
| Feb 6, 2023 | Amendment | $17,500,000 | $7,500,000vs Jul 28, 2022 | 20 | SEC filing |
| Jul 28, 2022 | Initial | $10,000,000 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-538674
Total Offering Amount and Total Amount Sold includes conversion of outstanding indebtedness in the amount of $5,122,990.09.
Source: Form D, filed Feb 19, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tim Harkness | Director |
| Joseph D. Keegan | Director |
| Jason Novi | Executive |
| William Snider | Director |
| Bill Snider | Director |
| Chad Souvignier | Director |
| Anne Rogove Stone | Director |
| David Weber | Director |
| Robert Wicke | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
21124 Cabot Blvd.
Hayward, CA, 94545
Hayward, CA, 94545